irofulven has been researched along with Kaposi Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koeppel, F; Larsen, AK; Lazar, V; Poindessous, V; Raymond, E; Sarasin, A | 1 |
1 other study(ies) available for irofulven and Kaposi Disease
Article | Year |
---|---|
Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cells.
Topics: Antineoplastic Agents, Alkylating; Base Sequence; Cell Division; Cell Line, Tumor; Cell Survival; Cells, Cultured; Cockayne Syndrome; DNA Primers; DNA Repair; DNA-Binding Proteins; DNA, Neoplasm; Endonucleases; Humans; Nuclear Proteins; Sesquiterpenes; Transcription Factors; Transcription, Genetic; Xeroderma Pigmentosum | 2004 |